SYY Form 4: Executive Award of RSUs and Options, Vesting Through 2028
Rhea-AI Filing Summary
Sysco insider transactions: SVP and CAO Jennifer L. Johnson reported equity awards and related withholding activity. On 08/21/2025 she was granted 3,767 restricted stock units (RSUs) under the 2018 Omnibus Incentive Plan that vest in three equal annual installments beginning 08/21/2026. The same date shows a grant of 10,024 stock options with an exercise price of $80.98; one-third vests and becomes exercisable each year starting 08/21/2026 and the options expire 08/20/2035. On 08/22/2025, 315 shares were withheld to satisfy tax withholding upon RSU vesting, leaving Johnson with 15,448 common shares beneficially owned after the transactions.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine executive equity grant and tax withholding consistent with annual incentive programs; vesting schedule aligns pay with tenure.
The 3,767 RSUs and 10,024 options are standard long-term incentive instruments used to retain senior executives and align pay with shareholder outcomes. The one-third annual vesting over three years for both RSUs and options encourages continued service. The option exercise price of $80.98 establishes the performance hurdle for intrinsic value creation. Withholding of 315 shares to cover taxes is a typical administrative action and reduces net shares immediately held.
TL;DR: Disclosure is a routine Section 16 Form 4 reporting grant and withholding; no unusual trading or immediate liquidation.
The Form 4 documents awards granted by the Compensation and Leadership Development Committee under the 2018 Omnibus Incentive Plan and subsequent tax withholding. Transaction codes (A for grant, F for shares withheld) and the signature by attorney-in-fact indicate timely and proper Section 16 reporting. There is no sale or transfer suggesting liquidity events by the reporting person.